LIQUIDITY ALERT: Biozone Pharma Has US$1.1 Million Current Deficit
September 23, 2011
As of June 30, 2011, Biozone Pharmaceuticals, Inc. had cash and cash equivalents of US$1,839,685 and negative working capital of US$1,098,943. The Company had cash and cash equivalents of US$251,475…
COMPANIES:
Biozone Pharmaceuticals Inc